COVID-19 Protein Expression

COVID-19 Protein Expression

The 2019 novel coronavirus (provisionally named 2019-nCoV) is a contagious virus that causes respiratory infection. From genomic sequencing, it has been shown as a positive-sense, single-stranded RNA coronavirus. The virus was first detected in Wuhan, China, in mid-December 2019 and subsequently spreads to all provinces of China and to more than twenty other countries over the world. Creative Biostructure has established an advanced COVID-19 targeted discovery platform to offer a wide variety of products and services to accelerate your research for structure/function study and novel drug discovery. Our featured services and products include:

Expression and purification of COVID-19 structural proteins. We provide multiple approaches for expression and purification of coronavirus structural proteins, including Cell-based Protein Expression, Cell-free Protein Expression, Virus-like Particle (VLP) Construction, Nanodiscs Construction, and Liposome-based Protein Construction.

Structural characterization of COVID-19 proteins. We provide sophisticated 3-D structure determination methods for the functional study of COVID-19. These methods include NMR, X-ray Crystallography, and Cryo-Electron Microscopy.

COVID-19 related products. We provide a wide range of virus-like particle (VLP) related products that can be used for functional characterization of COVID-19.

https://www.creative-biostructure.com/discovery-program-for-covid-19-targets-669.htm